cefoperazone has been researched along with Lyme Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auwaerter, PG; Feng, J; Zhang, Y | 1 |
Eber, B; Gasser, RN; Klein, W; Pokan, R; Reisinger, EC; Seinost, G; Wendelin, I | 1 |
Berglöff, J; Eber, B; Gasser, R; Horwarth, R; Klein, W; Pokan, R; Reisinger, E; Sedaj, B; Seinost, G | 1 |
3 other study(ies) available for cefoperazone and Lyme Disease
Article | Year |
---|---|
Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.
Topics: Anti-Bacterial Agents; Borrelia burgdorferi; Cefoperazone; Daptomycin; Doxycycline; Drug Therapy, Combination; Humans; Lyme Disease | 2015 |
Treatment of late Lyme borreliosis with cefoperazone and sulbactam.
Topics: Adult; beta-Lactam Resistance; Borrelia burgdorferi Group; Cefoperazone; Drug Therapy, Combination; Humans; Immunoglobulin G; Lyme Disease; Male; Sulbactam | 1995 |
Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
Topics: beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Lyme Disease; Male; Middle Aged; Sulbactam | 1995 |